Wen-Juei Jeng

47PUBLICATIONS
62CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Behavioural epidemiologyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursOther health sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jun 01, 2026
Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance.

|Jul 02, 2025
Switching to Entecavir >3 Months Before the End of Tenofovir-Based Therapy in Hepatitis B e Antigen-Negative Patients May Reduce Early Relapse and Hepatitis Flare.

Yi-Cheng Chen, Wen-Juei Jeng, Rong-Nan Chien

|Mar 14, 2025
Letter: No Biochemical Relapse Is Associated With the Highest Off-Therapy HBsAg Loss Rate.

Wen-Juei Jeng, Yun-Fan Liaw

|Jan 17, 2025
Higher Relapse Rate in HBeAg-Negative Patients After Cessation of Tenofovir Alafenamide Compared With Entecavir or Tenofovir Disoproxil Fumarate.

Hsin-Wei Fang, Wen-Juei Jeng, Tsung-Hui Hu

|Sep 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.

Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng

|Jun 05, 2024
Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival.

Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw

Pageof 8

Frequent Collaborators

13 joint publications

Yun-Fan Liaw

10 joint publications

Yen-Chun Liu

8 joint publications

Rong-Nan Chien

5 joint publications

Hwai-I Yang